Ads
related to: latest on diabetes research articles- Donate to Fight Diabetes
Make a difference
Choose Your Donation Amount
- We Fight T-Shirt
Donate $50 For Your Tee
Join The Fight To End Diabetes
- Double Your Impact
Your Support Counts Double Today
Donations Matched 2x In September
- Employer Gift Matching
Check Employer Match Eligibility
Have Your Employer Double Your Gift
- Donate to Fight Diabetes
Search results
Results from the WOW.Com Content Network
Depression among people with diabetes remains a key health area to address. There has been recent interest in whether glucagon-like peptide-1 receptor agonists (GLP-1RAs) affect depression risk.
Breakthrough T1D was founded in 1970 by a group of parents of children living with type 1 diabetes. [9] The founding members formed the organization with the intent to find a cure for type 1 diabetes and its complications by supporting research.
Articles in JDST cover both basic research and clinical applications of technologies being developed to help people with diabetes. It is published by SAGE Publishing on behalf of the Diabetes Technology Society. The journal was established in 2007 and the editor-in-chief is David C. Klonoff (Mills Peninsula Health Services).
The law provided $150 million for type 1 diabetes research in FY 2009. July 15, 2008—The Medicare Improvements for Patients and Providers Act of 2008 (P.L. 110–275) extended funding for the Special Statutory Funding Program for Type 1 Diabetes Research. The law provided $150 million per year for type 1 diabetes research in FY 2010 and FY 2011.
A new study finds a significant link between the use of semaglutide drugs such as Ozempic, which are often used for weight loss, antidepressant, or benzodiazepine use, and suicidal ideation.
Diabetic Drugs for Weight Loss. Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re one of the millions of adults ...
The EASD, as an academic non-profit association, benefits from the possibilities offered by the legal status of its Foundation to advance diabetes research by various methods. Since its inception, EFSD has committed an amount approaching Euro 100 million to diabetes research in Europe by various funding means.
The German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at Heinrich Heine University (HHU), is a research institution based in Düsseldorf. In 1964, it was founded due to the initiative of Prof. Dr. med. Karl Oberdisse as an Association for the Promotion of Research on Diabetes mellitus (Gesellschaft zur Förderung der Erforschung der Zuckerkrankheit e.V.).
Ads
related to: latest on diabetes research articles